Cytotoxic memory T cells play a critical role in combating viral infections; however, in some diseases they may contribute to tissue damage. In HAM/TSP, HTLV-1 Tax 11 -19+ cells proliferate spontaneously in vitro and can be tracked using the Tax 11 -19 MHC Class I tetramer. Immediately ex vivo, these cells were a mix of CD45RA À /CCR7 À T EM and CD45RA + /CCR7 À T Diff memory CTL. The subsequent proliferating Tax 11 -19 tetramer+ population expressed low levels of IL-7Ra, failed to respond to IL-7 and IL-15, and did not develop a T CM phenotype. Thus, chronic exposure to viral antigen may result in a sustained pool of T EM cells that home to the CNS and mediate the spinal cord pathology seen in this disease. D
Introduction
Human T-cell lymphotropic virus type-1 (HTLV-1) is the etiologic agent of both adult T-cell leukemia (ATL) (Hinuma et al., 1981; Poiesz et al., 1981; Yoshida et al., 1982) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (Gessain et al., 1985; Osame et al., 1986; Rodgers-Johnson et al., 1985) . HAM/TSP is a chronic inflammatory disorder, predominantly affecting the brain and spinal cord, and characterized by weakness, spasticity of the lower extremities, urinary incontinence, and hyperreflexia (Levin and Jacobson, 1997). Remarkably, in HAM/TSP A2+ patients up to 30% of circulating CD8 cells are specific for Tax 11 -19, the immunodominant peptide from the viral transactivator protein Tax, with much higher frequencies found in patients with HAM/TSP, as compared with healthy carriers (Bieganowska et al., 1999; Jeffery et al., 1999; Sakai et al., 2001) . HAM/TSP patients also have much higher proviral loads than healthy carriers suggesting that there is failed clearance of the virus by cytotoxic T cells (CTL) and this has been linked with disease severity (Manns et al., 1999; Nagai et al., 1998; Yamano et al., 2002) . A direct pathogenic role for the HTLV-1 Tax specific CTL has been proposed based on their presence in the cerebrospinal fluid (CSF) of patients with HAM/TSP, and in CNS lesions where they likely mediate disease pathology by secreting inflammatory cytokines and proteases (Biddison et al., 1997; Jacobson et al., 1990; Kubota et al., 2002; Levin et al., 1997; Nagai et al., 2001a,b) .
A fundamental goal in immunology is to define the mechanisms that allow the maintenance and rapid regeneration of effector memory T cell responses in order to improve our ability to prime protective immune responses and combat damaging ones. Human memory T-cells can be
